γ-Tocotrienol Inhibits TGF-β1-Induced Contractile Phenotype Expression of Human Airway Smooth Muscle Cells

Takehito Fukushima1, Akira Yamasaki1, Tomoya Harada1

  • 1Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, school of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.

Yonago Acta Medica
|March 24, 2017
PubMed
Abstract

Insights

Gamma-tocotrienol, a vitamin E form, may benefit asthma by inhibiting airway remodeling. It suppresses transforming growth factor-beta (TGF-β) activation of RhoA, reducing airway smooth muscle cell changes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Tocotrienols, vitamin E isoforms, show neuroprotective and anticancer properties.
  • Gamma-tocotrienol inhibits PDGF-BB-induced airway smooth muscle cell proliferation and migration via RhoA suppression.
  • This study investigates gamma-tocotrienol's effect on TGF-β-induced airway smooth muscle cell changes.

Purpose of the Study:

  • To determine if gamma-tocotrienol modulates TGF-β-induced airway smooth muscle cell (ASM) differentiation.
  • To assess the impact of gamma-tocotrienol on extracellular matrix protein synthesis in ASM cells.
  • To explore the signaling pathways involved in TGF-β-induced ASM remodeling and gamma-tocotrienol's influence.

Main Methods:

  • Human airway smooth muscle cells were stimulated with TGF-β1.
  • The effects of gamma-tocotrienol on α-smooth muscle actin, fibronectin, and collagen I expression were analyzed via Western blotting.
  • Signaling pathways, including RhoA, Smad2, and Smad3, were investigated.

Main Results:

  • TGF-β1 significantly increased α-smooth muscle actin, fibronectin, and collagen I levels (3-5 fold).
  • Gamma-tocotrienol administration markedly inhibited these TGF-β1-induced increases.
  • Gamma-tocotrienol suppressed RhoA activation but did not affect Smad2 or Smad3 phosphorylation.

Conclusions:

  • Gamma-tocotrienol demonstrates potential in mitigating airway remodeling in asthma.
  • The mechanism likely involves the suppression of TGF-β-induced RhoA activation by gamma-tocotrienol.
  • Further research into gamma-tocotrienol for asthma treatment is warranted.